Skip to main content
News & Announcements

Unlocking True Partnerships: Going Beyond Science in Outsourcing Formulation Development & Manufacturing

Hexagons on blue gradient background

This article by Drug Development & Delivery highlights the importance of Contract Development and Manufacturing Organizations (CDMOs) for the pharma and biotech companies when it comes to advancing innovative therapies. 

In this annual report, lead­ing CDMOs speak with Drug Development & Delivery about how they are adapting to bio/pharma client needs. In addition, this report also discusses the integrated CDMO/CRO services offered by Quotient Sciences and how the company’s Translational Pharmaceutics® platform in­tegrates formulation development, on-de­mand and adaptive GMP manufacturing, healthy volunteer clinical testing, data analysis and full regulatory support within a single organization.

To read more, check out the full article here on the Drug Development & Delivery website.

Latest news from Quotient Sciences

More News
Articles & Publications, Dr. Andy Lewis, AI, Clinical Trials The Future of Pharma: How AI is Transforming the Industry By: Dr. Andrew Lewis
Read More
formulation development, GLP-1, Peptides, Dr. Andy Lewis, Dr. Andrew Parker Video Interview: Dr. Andrew Lewis and Dr. Andrew Parker Speak with Manufacturing Chemist at CPHI Milan
Read More
Get in touch
Humanity can't afford to wait, so neither can we.